Randomized phase II trial of maintenance autologous tumor cell vaccine (FANG™) following clinical complete response (cCR) in stage III/IV ovarian cancer: Preliminary results

Autor:	Evelyn Fleming, C.A. Stringer, Neil Senzer, T.P. Heffernan, Elizabeth A. Grosen, Carolyn M. Matthews, E.C. Koon, Howard M. Goodman, Minal A. Barve, M.S. Bergman, John Nemunaitis, Jonathan Oh, B.A. Fine, Leslie R. DeMars
Rok vydání:	2015
Předmět:	Oncology medicine.medical_specialty Pathology business.industry Obstetrics and Gynecology medicine.disease Clinical complete response Internal medicine Autologous Tumor Cell Vaccine medicine Stage (cooking) Ovarian cancer business
Zdroj:	Gynecologic Oncology. 137:2-3
ISSN:	0090-8258
DOI:	10.1016/j.ygyno.2015.01.003
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e0227c5abbc8548754489510c3eb58b8 https://doi.org/10.1016/j.ygyno.2015.01.003 Zobrazit plný text záznamu Full Text from ScienceDirect